CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for PharmaResources Shanghai Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

PharmaResources Shanghai Co Ltd
Building 23
No. 315, Qingda Road, Pudong New Area
Phone: +86 2150720100p:+86 2150720100 SHANGHAI, SHA  201201  China Ticker: 301230301230
Business Summary
PharmaResources Shanghai Co Ltd is a China-based company mainly engaged in the development and commercial production of new drugs. The Company's main businesses include drug discovery, process research and development and commercial manufacturing business. The drug discovery business includes medicinal chemistry, synthetic chemistry and pharmacokinetics. The process research and development business includes process chemistry and process development as well as bulk drug research. The commercial manufacturing business includes customized manufacturing of new drugs and the research and development, production and sales of proprietary generic drug products. The Company distributes its products to the United States, India and other countries.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202312/31/2022Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager PingChen 64 11/30/2015 11/30/2015
Chief Financial Officer ShichengLi 46 11/30/2015 11/30/2015
Deputy General Manager, Secretary of the Board, Director ShengliJiang 52 11/30/2015 11/30/2015
7 additional Officers and Directors records available in full report.

General Information
Number of Employees: 983 (As of 12/31/2022)
Outstanding Shares: 107,622,666 (As of 2/21/2024)
Shareholders: 11,128
Stock Exchange: SHE
Fax Number: +86 2150720097


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 19, 2024